NR
Narsimha Reddy Bommineni
About Narsimha Reddy Bommineni
Data last updated:
Narsimha Reddy Bommineni is a Director at Indo-Swiss Remedies Private Limited (since 2014) and Director at Pjs Pharma Private Limited (since 2018). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹2.60 Cr; the largest is Indo-Swiss Remedies Private Limited at ₹1.89 Cr (FY 2024). Earlier, Narsimha Reddy Bommineni was a Director at Care Biologicals Private Limited (2010–2021) and Additional Director at Aimchem Pharma Private Limited (2019) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Indo-Swiss Remedies Private Limited U24240TG2014PTC095123 | Director | 04 Aug 2014 | 2014 | ₹1.89 Cr (FY 2024) | Active |
 Pjs Pharma Private Limited U24296TG2015PTC101062 | Director | 15 Sep 2018 | 2015 | ₹70.6 Lakh (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Care Biologicals Private Limited U24232TG2010PTC071157 | Director | 11 Nov 2010 | 2010 | ₹38,897 (FY 2020) | Active |
| Aimchem Pharma Private Limited U24100TG2018PTC122882 | Additional Director | 25 Feb 2019 | 2018 | ₹7 Lakh (FY 2019) | Active |
| Rvn Pharma Private Limited U15134TG2020PTC146465 | Director | 02 Dec 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narsimha Reddy Bommineni
| Name | DIN | Company | Designation |
|---|---|---|---|
| Devendar Rao Thutika | 06843675 | Indo-Swiss Remedies Private Limited | Director |
| Saritha Bachu | 07334246 | Indo-Swiss Remedies Private Limited | Director |
| Sushma Reddy Gujjula | 07495705 | Indo-Swiss Remedies Private Limited | Director |
| Vikas Reddy Andru | 11237072 | Indo-Swiss Remedies Private Limited | Director |
| Prabhakar Rao Pasem | 08202856 | Pjs Pharma Private Limited | Director |
| Prasanna Lakshmi Palle | 07280618 | Pjs Pharma Private Limited | Director |
| Sreenivas Bommagani | 07280617 | Pjs Pharma Private Limited | Director |
| Sudhakar Rao Kota | 08098646 | Pjs Pharma Private Limited | Director |
| Vasantha Madhava Sharma Gangavaram | 08202521 | Pjs Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narsimha Reddy Bommineni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narsimha Reddy Bommineni
Narsimha Reddy Bommineni currently holds 2 directorships: Indo-Swiss Remedies Private Limited (Director, since 04 Aug 2014, revenue ₹1.89 Cr (FY 2024)); Pjs Pharma Private Limited (Director, since 15 Sep 2018, revenue ₹70.6 Lakh (FY 2023)).
Narsimha Reddy Bommineni was first appointed on 11 Nov 2010 as Director at Care Biologicals Private Limited. The most recent appointment on record is 02 Dec 2020 at Rvn Pharma Private Limited.
The 2 current companies of Narsimha Reddy Bommineni that report revenue have a combined latest revenue of ₹2.60 Cr: Indo-Swiss Remedies Private Limited ₹1.89 Cr (FY 2024); Pjs Pharma Private Limited ₹70.6 Lakh (FY 2023).
Narsimha Reddy Bommineni held 3 earlier board appointments: Care Biologicals Private Limited (Director, 11 Nov 2010 to 11 Jun 2021); Aimchem Pharma Private Limited (Additional Director, 25 Feb 2019 to 20 Aug 2019); Rvn Pharma Private Limited (Director, from 02 Dec 2020).
The current boards of Narsimha Reddy Bommineni's companies include Devendar Rao Thutika (Indo-Swiss Remedies Private Limited), Saritha Bachu (Indo-Swiss Remedies Private Limited), Sushma Reddy Gujjula (Indo-Swiss Remedies Private Limited), Vikas Reddy Andru (Indo-Swiss Remedies Private Limited), Prabhakar Rao Pasem (Pjs Pharma Private Limited), Prasanna Lakshmi Palle (Pjs Pharma Private Limited), among others.